Prevention of UV-carcinogenesis through DNA repair-dependent immunomodulation
通过 DNA 修复依赖性免疫调节预防紫外线致癌
基本信息
- 批准号:8210888
- 负责人:
- 金额:$ 33.17万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-07-01 至 2014-12-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAddressAdverse effectsAffectAgeAnimal ModelAntigensArtichokeBone Marrow TransplantationCaucasiansCaucasoid RaceCellsChemopreventive AgentChronicContact hypersensitivityCosmeticsCutaneous MelanomaDNA DamageDNA RepairDataDefectDendritic CellsDevelopmentDevicesEffector CellEnvironmentEquilibriumExcisionExpenditureExposure toFamilyFlavonoidsGenerationsGeneticGoalsHaptensHealthcareHumanImmune responseImmune systemImmunosuppressionImmunosuppressive AgentsIn VitroIncidenceInflammation MediatorsInterferonsInterleukin-10Interleukin-12Interleukin-4Interleukin-5KnowledgeLangerhans cellLeadLinkMalignant NeoplasmsMediatingMilk ThistleMolecularMusNucleotide Excision RepairOzonePhytochemicalPlantsPopulationPreventionPreventiveProductionPublic HealthPyrimidine DimersRegulatory T-LymphocyteRiskSilymarinSkinSkin CancerSkin CarcinomaSkin NeoplasmsSkin TissueSkin tanningSquamous cell carcinomaSuppressor-Effector T-LymphocytesSurfaceT-Cell ActivationT-LymphocyteTestingTh2 CellsThe SunUV Radiation ExposureUV inducedUVB inducedUltraviolet RaysUnited Statesbasecarcinogenesiscytokineimmunoregulationimprovedin vivoinsightmembermouse modelnovelpreventpublic health relevancerepairedresearch studyresponserestorationskin cancer preventiontumorultravioletultraviolet irradiation
项目摘要
DESCRIPTION (provided by applicant): The goals of the proposed studies are to: (1) Identify the mechanisms by which silymarin, a phytochemical obtained from milk thistle (Silybum marianum L.), ameliorates ultraviolet (UV) radiation-induced immunosuppression and DNA damage; and (2) Determine the contribution of these mechanisms to silymarin-mediated prevention of skin cancer. Both UV-induced DNA damage, in the form of cyclobutane pyrimidine dimers (CPDs), and immune suppression have been shown to be associated with an increased risk of skin cancer. We have demonstrated that topical treatment with silymarin provides significant protection against both UV-induced immunosuppression and carcinogenesis in an in vivo mouse model. UV irradiation is known to impair the function of dendritic cells and effector T cells but induce suppressor T cells. Furthermore, UV-induced DNA damage, predominantly the formation of CPDs, is an important molecular trigger for UV-mediated immunosuppression. We have demonstrated that silymarin has the ability to enhance the removal or repair of CPD+ cells in UV-exposed skin, and inhibits UVB-induced suppression of the contact hypersensitivity response in mice. Our preliminary data further indicate that silymarin can enhance the removal of CPDs in UV-exposed dendritic cells and restore dendritic cell-mediated activities including stimulation of T cells. However, silymarin mediated inhibition of UV-induced immunosuppression is abolished in mice that have defect in DNA repair. Collectively, these data implicate key links between the ability of silymarin to inhibit UV-induced immunosuppression and its ability to prevent photocarcinogenesis. Our hypothesis is that the repair of UVB-induced DNA damage by silymarin is critical for its chemopreventive effects on UV-induced immunosuppression and photocarcinogenesis. We propose four inter-related Specific Aims in which we will use genetically modified mouse model, including nucleotide excision repair-deficient mice: (1) Determine whether silymarin inhibits the development of UV-induced tolerogenic dendritic cells through restoration of dendritic cell activity; (2) Determine whether silymarin- induced inhibition of UV-induced immunosuppression occurs through enhancement of T-cell activation, (3) Determine whether silymarin inhibits the development of UV-induced regulatory T cells; and (4) Determine whether silymarin inhibition of photocarcinogenesis is mediated through DNA repair. The proposed studies should identify the mechanisms by which silymarin acts to correct UV-induced immunosuppression in photocarcinogenesis. We address a major public health concern as overexposure of the human skin to solar UV radiation is the major etiologic factor for the development of melanoma and non-melanoma skin cancers in the United States. The development of new strategies using silymarin may help to reduce the risk of skin cancer in humans.
PUBLIC HEALTH RELEVANCE: Chronic exposure of the skin to solar ultraviolet (UV) radiation induces multiple adverse effects including the risk of skin cancer development. In vitro and in vivo studies have indicated that silymarin, a plant flavonoid obtained from milk thistle, possesses potent anti-photocarcinogenic activity. In the current application, we will determine the molecular mechanism of prevention of photocarcinogenesis by silymarin. This study will also highlight that rapid repair of UVB-induced DNA damage by silymarin will result in the enhancement or restoration of immune system and that will lead to the prevention of UV-carcinogenesis. The generation of new knowledge will provide novel insights into the mechanisms by which silymarin can either correct, or compensate for, the UV-induced damage that triggers or promotes photocarcinogenesis.
描述(由申请人提供):拟议研究的目标是:(1)确定水飞蓟素,一种从水飞蓟(Silybum marianum L.)中获得的植物化学物质,改善紫外线(UV)辐射诱导的免疫抑制和DNA损伤;(2)确定这些机制对水飞蓟素介导的皮肤癌预防的贡献。紫外线诱导的DNA损伤,以环丁烷嘧啶二聚体(CPD)的形式,和免疫抑制已被证明与皮肤癌的风险增加有关。我们已经证明,局部治疗与水飞蓟素提供了显着的保护,对紫外线诱导的免疫抑制和致癌作用在体内小鼠模型。已知UV照射损害树突状细胞和效应T细胞的功能,但诱导抑制性T细胞。此外,UV诱导的DNA损伤,主要是CPD的形成,是UV介导的免疫抑制的重要分子触发剂。我们已经证明,水飞蓟素有能力提高去除或修复CPD+细胞在紫外线暴露的皮肤,并抑制UVB诱导的小鼠接触性超敏反应的抑制。我们的初步数据进一步表明,水飞蓟素可以增强紫外线暴露的树突状细胞中CPD的去除,并恢复树突状细胞介导的活动,包括刺激T细胞。然而,水飞蓟素介导的抑制UV诱导的免疫抑制在具有DNA修复缺陷的小鼠中被废除。总的来说,这些数据暗示了水飞蓟素抑制紫外线诱导的免疫抑制的能力和其防止光致癌作用的能力之间的关键联系。我们的假设是,修复UVB诱导的DNA损伤的水飞蓟素是至关重要的紫外线诱导的免疫抑制和光致癌的化学预防作用。我们提出了四个相互关联的具体目标,其中我们将使用转基因小鼠模型,包括核苷酸切除修复缺陷小鼠:(1)确定水飞蓟素是否通过恢复树突状细胞活性来抑制UV诱导的耐受性树突状细胞的发育;(2)确定水飞蓟素诱导的对UV诱导的免疫抑制的抑制是否通过增强T细胞活化而发生,(3)确定水飞蓟素是否抑制UV诱导的调节性T细胞的发育;和(4)确定水飞蓟素对光致癌作用的抑制是否通过DNA修复介导。拟议的研究应确定的机制,水飞蓟素的行为,以纠正紫外线诱导的免疫抑制在光致癌作用。我们解决了一个主要的公共卫生问题,因为人类皮肤过度暴露于太阳紫外线辐射是美国黑色素瘤和非黑色素瘤皮肤癌发展的主要病因因素。使用水飞蓟素的新策略的开发可能有助于降低人类皮肤癌的风险。
公共卫生关系:皮肤长期暴露于太阳紫外线(UV)辐射会引起多种不良影响,包括患皮肤癌的风险。体外和体内研究表明,水飞蓟素是一种从水飞蓟中提取的黄酮类化合物,具有很强的抗光致癌活性。在当前的应用中,我们将确定水飞蓟素预防光致癌作用的分子机制。本研究还将强调,快速修复UVB诱导的DNA损伤的水飞蓟素将导致增强或恢复免疫系统,这将导致预防紫外线致癌。新知识的产生将为水飞蓟素纠正或补偿引发或促进光致癌作用的UV诱导损伤的机制提供新的见解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SANTOSH KUMAR KATIYAR其他文献
SANTOSH KUMAR KATIYAR的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SANTOSH KUMAR KATIYAR', 18)}}的其他基金
Prevention of UV-carcinogenesis through DNA methylation-dependent immunomodulation
通过 DNA 甲基化依赖性免疫调节预防紫外线致癌
- 批准号:
8883008 - 财政年份:2015
- 资助金额:
$ 33.17万 - 项目类别:
Prevention of UV-carcinogenesis through DNA methylation-dependent immunomodulation
通过 DNA 甲基化依赖性免疫调节预防紫外线致癌
- 批准号:
9070629 - 财政年份:2015
- 资助金额:
$ 33.17万 - 项目类别:
Proanthocyanidins,Novel bioactive components for prevention of melanoma invasion
原花青素,预防黑色素瘤侵袭的新型生物活性成分
- 批准号:
8442533 - 财政年份:2013
- 资助金额:
$ 33.17万 - 项目类别:
Proanthocyanidins,Novel bioactive components for prevention of melanoma invasion
原花青素,预防黑色素瘤侵袭的新型生物活性成分
- 批准号:
8601917 - 财政年份:2013
- 资助金额:
$ 33.17万 - 项目类别:
Prevention of photocarcinogenesis by dietary immunomodulation
通过饮食免疫调节预防光致癌
- 批准号:
8431273 - 财政年份:2012
- 资助金额:
$ 33.17万 - 项目类别:
Prevention of photocarcinogenesis by dietary immunomodulation
通过饮食免疫调节预防光致癌
- 批准号:
8698300 - 财政年份:2012
- 资助金额:
$ 33.17万 - 项目类别:
Prevention of photocarcinogenesis by dietary immunomodulation
通过饮食免疫调节预防光致癌
- 批准号:
8240922 - 财政年份:2012
- 资助金额:
$ 33.17万 - 项目类别:
Prevention of photocarcinogenesis by dietary immunomodulation
通过饮食免疫调节预防光致癌
- 批准号:
8803280 - 财政年份:2012
- 资助金额:
$ 33.17万 - 项目类别:
Epigenetic modulation by green tea in prevention of photocarcinogenesis
绿茶的表观遗传调节预防光致癌
- 批准号:
7895438 - 财政年份:2010
- 资助金额:
$ 33.17万 - 项目类别:
Epigenetic modulation by green tea in prevention of photocarcinogenesis
绿茶的表观遗传调节预防光致癌
- 批准号:
8033727 - 财政年份:2010
- 资助金额:
$ 33.17万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 33.17万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 33.17万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 33.17万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 33.17万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 33.17万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 33.17万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 33.17万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 33.17万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 33.17万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 33.17万 - 项目类别:
Research Grant